POOR-RISK GERM CELL TUMORS: Recent Developments
- 1 August 1998
- journal article
- Published by Elsevier BV in Urologic Clinics of North America
- Vol. 25 (3), 485-493
- https://doi.org/10.1016/s0094-0143(05)70038-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.Journal of Clinical Oncology, 1997
- A Phase II Trial of VP-16, Ifosfamide, Cisplatin, Vinblastine, and Bleomycin in Advanced Germ-Cell TumorsAmerican Journal of Clinical Oncology, 1996
- Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative GroupBritish Journal of Cancer, 1995
- Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.Journal of Clinical Oncology, 1995
- High-Dose Chemotherapy for Resistant Germ Cell Tumors: Recent Advances and Future DirectionsJNCI Journal of the National Cancer Institute, 1992
- BOP/VIP - A new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumoursAnnals Of Oncology, 1991
- Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.Journal of Clinical Oncology, 1989
- A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.Journal of Clinical Oncology, 1988
- Prognostic factors in advanced nonseminomatous testicular cancer a multivariate logistic regression analysisCancer, 1988
- The Role of Maintenance Therapy in Disseminated Testicular CancerNew England Journal of Medicine, 1981